immunogenic peptides

immunogenic peptides

[‚im·yə·nō‚jen·ik ′pep‚tīdz]
(immunology)
Peptides that are recognized by T cells primed by immunization or transplantation.
References in periodicals archive ?
Reduced acidity (elevated pH) reduces ability to absorb minerals including those needed for prevention of asthma, prevent uptake of metal toxins, and break down immunogenic peptides.
The topics include generating cytotoxic T lymphocytes for the immunotherapy of EBV-associated malignancies, the enhanced migration of human dendritic cells expressing inducible CD40, constructing human antibody gene libraries and selecting antibodies by phage display, using telomerase reverse transcriptase to identify immunogenic peptides of the self-tumor antigen, liposomes for gene transfer in cancer therapy, and the cellular immunotherapy of cancer.
The patents, titled "METHOD OF AFFINITY CROSS-LINKING BIOLOGICALLY ACTIVE, IMMUNOGENIC PEPTIDES TO ANTIBODIES," relate to the Company's ability to create, develop and manufacture antibodies based on its DXL(TM) technology platform.
Degenerate binding of immunogenic peptides to HLA-DR proteins on B cell surfaces.
The strategy was focused on the HER-2/neu-expressing DCIS because of the frequent association with recurrent disease and of course the availability of both major histocompatibility complex (MHC) class 2 and class 1 restricted immunogenic peptides.
Among the different immunogenic peptides, one peptide, with a sequence of Cys-YTLRAPRSPKMVQG, appeared to be the most appropriate candidate, as most immunized mice produced antibodies specific for the pro[BNP.
Once the immunogenic peptides are identified, specific tetramers for those peptides can be developed to monitor immune response to the vaccine.
In addition, genes involved in coding cancer antigens have been identified, along with the immunogenic peptides associated with these antigens.
T Cell Receptor (TCR) recognition of immunogenic peptides bound to major histocompatibility complex (MHC) molecules leads to T cell activation and a variety of effector functions.
Additional studies showed that BL-7010 is specific to gliadins, the immunogenic peptides present in gluten that cause celiac disease, and does not interact with non-related enzymes or vitamins in the digestive tract.
The invention provides immunogenic compositions comprising PAGE-4 protein or immunogenic peptides thereof, methods of inhibiting the growth of malignant cells expressing PAGE-4, and methods of inducing an enhanced immune response to PAGE-4-expressing cancers.
In addition, gp96 enables specific immune responses by transferring immunogenic peptides to MHC class I molecules, thus facilitating antigen specific activation of cytotoxic T cells.